Shares of Summit Therapeutics, whose cancer drug candidate turned heads after it outperformed a blockbuster drug from Merck, ...

Ghostery's CEO and Director of Engineering break down the new Manifest V3 changes, and why they're bad news for anyone who ...

Intuit's revenue growth is decelerating, especially in the SMB segment. Click here to find out the factors that make me ...

Nichola, a colleague, informed me that she had received a message from her friend on WhatsApp (WA) asking her to share a ...